As of Nov 2, 2026: Amit Etkin (CEO, ANRO) reported no shares bought or sold themselves in the last 12 months (Form 4). ANRO's Quality Score is -6. Scores as of 6:18 PM ET, 15 minutes behind.

Amit Etkin

President and CEO of Alto Neuroscience

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for May 14: gift (400,000 ANRO shares).

Bought$012 months Sold$012 months Last filedMay 14gift

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Amit Etkin reported

None in the last 12 months, as filed.

Their filings on the SEC's siteEvery Form 4 they filed, as filed, on EDGAR.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See ANRO's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Amit Etkin's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
ANROAlto NeuroscienceCEO	President and CEOfiled May 15	0	-6

Alerts for Amit Etkin

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated May 14, 2026.

Free to reuse with a link to this page.

How to cite

Breakaway, Amit Etkin: President and CEO at Alto Neuroscience (ANRO), May 14, 2026, getbreakaway.com/insiders/amit-etkin

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Alto Neuroscience

Nicholas Conrad SmithPresident and CFO

Insider trades by person